Document is current

Article History

Received: 26 June 2023

Accepted: 21 December 2023

First Online: 3 January 2024

Declarations

:

: Ethical approval for the STS was granted by the University College London Research Ethics Committee (0498/001; 2808/005). In accordance with ethical approval, all respondents were given a written information sheet about the study and provide informed verbal consent. The STROBE reporting guidelines for observational studies and the declaration of Helsinki (2013) were followed in the design and reporting of this study.

: Not applicable.

: Authors are members of the UK Prevention Research Partnership, an initiative funded by UK Research and Innovation Councils, the Department of Health and Social Care (England), and the UK devolved administrations and leading health research charities. JB reports receiving grants from Cancer Research UK during the conduct of the study and receiving unrestricted research funding from pharmaceutical companies (J&J and Pfizer) who manufacture smoking cessation medications to study smoking cessation outside the submitted work. LS reports receiving honoraria for talks, receiving an unrestricted research grant and travel expenses to attend meetings and workshops by pharmaceutical companies that make smoking cessation products (Pfizer and Johnson & Johnson), and acting as a paid reviewer for grant-awarding bodies and as a paid consultant for healthcare companies. LK, LB and CA have no competing interests to declare. CG and MO are paid scientific consultants for the behaviour change and lifestyle organisation ‘One Year No Beer’.